Introduction
Endoscopists will be well acquainted with gastro-oesophageal reflux disease (GORD) and eosinophilic oesophagitis (EoE) as the most common causes of oesophageal inflammation, each with distinctive endoscopic features and well established management strategies outlined in clinical guidelines 1–3. Whilst this forms the majority of presentations, it is important to be mindful of other rarer causes of oesophagitis, particularly in atypical presentations, to ensure correct management.
Drawing on current literature, this article will provide an overview of rare causes of oesophagitis, outlining their clinical presentations, endoscopic and histological findings, and management approaches. Systemic inflammatory and neuromuscular conditions, such as systemic sclerosis, SLE, Sjogren’s syndrome, mixed connective tissue disease, and dermatomyositis, may predispose to secondary GORD, by degrading oesophageal smooth muscle and causing oesophageal dysmotility, but whilst they justify awareness these conditions are not within the scope of this article 4,5.
Appreciation of rarer causes of oesophagitis will aid clinicians make timely diagnoses and implement appropriate interventions, ultimately improving patient outcomes.
With thanks to the Gastroenterology and Endoscopy department at Guys C St Thomas’ NHS Foundation Trust for use of these images.
Conclusion
Gastroenterologists must remain vigilant for rarer causes of oesophagitis that can present with similar symptoms and endoscopic appearances to GORD and EoE. These include autoimmune disorders, infections, and direct injury from ingested substances or medications. A thorough clinical history is often key to diagnosing these rare causes, providing essential clues that guide further testing and treatment. Whilst endoscopic appearances are non-specific for these conditions, any inflammation in the upper and mid oesophagus should warrant suspicion and appropriate further investigation. Prompt and accurate identification of these conditions is crucial for ensuring appropriate management.
Please see the author’s References list for this article after the below CME information.
Author Biography

Dr Joseph Cooney
Dr Cooney is a Locum Consultant Gastroenterologist at Guy’s and St Thomas’ NHS Foundation Trust. He graduated from St George’s Medical School in 2013 and completed his specialist training across several hospitals in London. He has a particular interest in therapeutic endoscopy, physiology, and oesophageal diseases, including eosinophilic oesophagitis, Barretts and motility disorders. He is completing a PhD at St George’s, University of London, on Novel Diagnostics and Therapeutics in Oesophageal Diseases. Dr Cooney serves as the trainee representative on the BSG Oesophageal Committee and is committed to both research and medical education.
CME
Quality Indicators in Barrett's Endoscopy: A Quest for the Holy Grail
27 October 2025
Factors associated with upper GI cancer occurrence after endoscopy
24 February 2025
- Trudgill, N. J. et al. British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring. Gut 68, 1731–1750 (2019)
- Dhar A. et al. British Society of Gastroenterology (BSG) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) joint consensus guidelines on the diagnosis and management of eosinophilic oesophagitis in children and adults. Gut 71, 1459–1487 (2022).
- National Institute for Health and Care Excellence. Gastro-Oesophageal Reffux Disease and Dyspepsia in Adults: Investigation and Management. https://www.nice.org.uk/guidance/cg184/resources/gastrooesophageal-reflux-disease-and-dyspepsia-in-adults- investigation-and-management-pdf-35109812699845 (2014).
- Reddy, C. A., McGowan, E., Yadlapati, R. C Peterson, K. AGA Clinical Practice Update on Esophageal Dysfunction Due to Disordered Immunity and Infection: Expert Review. Clinical Gastroenterology and Hepatology 22, 2378–2387 (2024).
- Arar, A. M., DeLay, K., Leiman, D. A. C Menard-Katcher, P. Esophageal Manifestations of Dermatological Diseases, Diagnosis, and Management. Curr Treat Options Gastro 20, 513–528 (2022).
- Kim, S. H. Clinical and endoscopic characteristics of drug-induced esophagitis. WJG 20, 10994 (2014).
- Abdi, S., Masbough, F., Nazari, M. C Abbasinazari, M. Drug-induced esophagitis and helpful management for healthcare providers. Gastroenterology and Hepatology from Bed to Bench 15, (2022).
- Pittman, M. E. Lymphocytic Esophagitis: Current Understanding and Controversy. American Journal of Surgical Pathology 46, e55– e63 (2022).
- Canalejo, E., García Durán, F., Cabello, N. C García Martínez, J. Herpes Esophagitis in Healthy Adults and Adolescents: Report of 3 Cases and Review of the Literature. Medicine 8G, 204–210 (2010).
- Sharma, D.D. et al. Contemporary Insights Into HIV Esophagitis: Pathogenesis, Therapeutic Strategies, and Prognostic Outcomes. Cureus (2024) doi:10.7759/cureus.60788.
- Xiong, J., Guo, W., Guo, Y., Gong, L. C Liu, S. Clinical and endoscopic features of esophageal tuberculosis: a 20-year retrospective study. Scandinavian Journal of Gastroenterology 55, 1200–1204 (2020).
- Grossi, L., Ciccaglione, A. F. C Marzio, L. Esophagitis and its causes: Who is ‘guilty’ when acid is found ‘not guilty’? World J. Gastroenterol. 23, 3011–3016 (2017).
- Murro, D. C Jakate, S. Radiation Esophagitis. Archives of Pathology & Laboratory Medicine 13G, 827–830 (2015).
- Park, J. et al. Churg-Strauss Syndrome as an Unusual Cause of Dysphagia: Case Report. Ann Rehabil Med 3G, 477 (2015).
- Gollu, G., Ergun, E., Ates, U., Can, O. S. C Dindar, H. Balloon dilatation in esophageal strictures in epidermolysis bullosa and the role of anesthesia: Dilatation in esophageal strictures in epidermolysis bullosa. Diseases of the Esophagus (2016) doi:10.1111/dote.12503.
- Chen, F. W., Liu, A. F., Srivastava, A., Buchbinder, E. C Grover, S. Checkpoint inhibitor induced esophagitis with documented resolution on infliximab. Current Problems in Cancer: Case Reports 2, 100029 (2020).
- Acero Brand, F. Z. et al. Severe immune mucositis and esophagitis in metastatic squamous carcinoma of the larynx associated with pembrolizumab. j. immunotherapy cancer 6, 22 (2018).
- Boike, J. C Dejulio, T. Severe Esophagitis and Gastritis from Nivolumab Therapy. ACG Case Reports Journal 4, e57 (2017).
- Rakovich, G. C Rolland, S. Necrotizing Esophagitis: A Big Squeeze? Journal of the Canadian Association of Gastroenterology 5, 103– 104 (2022).
- Leung, L. W. M. et al. Randomized comparison of oesophageal protection with a temperature control device: results of the IMPACT study. EP Europace 23, 205–215 (2021).
- Methasate, A. C Lohsiriwat, V. Role of endoscopy in caustic injury of the esophagus. WJGE 10, 274–282 (2018).
- Sami, S. S. et al. UK guidelines on oesophageal dilatation in clinical practice. Gut 67, 1000–1023 (2018).
- Hoffman, R. S., Burns, M. M. C Gosselin, S. Ingestion of Caustic Substances. N Engl J Med 382, 1739–1748 (2020).
- Ac, A. C Rajma, J. Candy Cane Appearance of the Esophagus Caused by Acute Thermal Injury. Clinical Gastroenterology and Hepatology 14, A19 (2016).
- Orosz, E. C Patel, A. V. Sloughing Mucosa in Esophagitis Dissecans Superficialis. Clinical Gastroenterology and Hepatology 1G, A41 (2021).
